Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis.
about
Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in childrenLooking toward basic science for potential drug discovery targets against community-associated MRSAStaphylococcus aureus bacteremia and buttonhole cannulation: long-term safety and efficacy of mupirocin prophylaxisMeta-analysis of methicillin-resistant Staphylococcus aureus colonization and risk of infection in dialysis patients.A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains.Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares.Mupirocin - Are we in danger of losing it?Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.Gentamicin-resistant infections in peritoneal dialysis patients using topical gentamicin exit-site prophylaxis: a report of two cases.Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.Clinical and Molecular Features of Decreased Chlorhexidine Susceptibility among Nosocomial Staphylococcus aureus Isolates at Texas Children's Hospital.Decolonization in Prevention of Health Care-Associated Infections.Preoperative use of mupirocin for the prevention of healthcare-associated Staphylococcus aureus infections: a cost-effectiveness analysis.Increased peritoneal dialysis exit site infections using topical antiseptic polyhexamethylene biguanide compared to mupirocin: results of a safety interim analysis of an open-label prospective randomized study.Comparing the Effect of Dressing Versus No-dressing on Exit Site Infection and Peritonitis in Chronic Ambulatory Peritoneal Dialysis PatientsPrevention of access-related infection in dialysis.Antibiotic overuse and resistance in dermatology.Prevention of central line-associated bloodstream infections in hemodialysis patients.Vascular access in therapeutic apheresis: update 2013.The economics of hemodialysis catheter-related infection prophylaxis.Prevention of peritonitis in peritoneal dialysis.Prevention of peritoneal dialysis-related infections.Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.Chlorhexidine for routine PD catheter exit-site care.Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.The Prevalence, Genotype and Antimicrobial Susceptibility of High- and Low-Level Mupirocin Resistant Methicillin-Resistant Staphylococcus aureus.Identification of Targets for Prevention of Peritoneal Catheter Tunnel and Exit-Site Infections in Low Incidence Settings.ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.Mupirocin resistance in clinical isolates of Staphylococcus aureus.Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
P2860
Q33560448-A85FABF4-E69F-451E-9BB3-47CE74FA5D4FQ33560722-5E7FE722-8D74-4119-B8AF-682291291668Q33888349-0E168DF5-2BF0-48AA-BFAD-2FF6EC490D87Q34103470-9CA61EB1-2BB3-41F3-BE2B-D34187EB2652Q34528933-611667B1-0677-435C-BC47-D6444E7D13E7Q34585413-519BE6C7-1E69-49B3-B86C-3C0CBEE93755Q35385754-15ABA5CE-A01A-492C-A59B-A4D6B062D291Q36170529-41A6DA7E-26CF-4063-A498-270DF9D11E03Q36295497-092C520C-B811-4F59-9095-9AD97DC0D667Q36474270-0931201B-B6AE-4482-AC5B-9F152D1D7AAEQ36474366-76227B0A-8967-4D66-96C7-969EE4077FCAQ36475698-D3AB6871-768B-4792-A424-CBEE1D8AC81DQ36505512-3A5C8FF8-7008-4C6B-87F9-B8F8789F55F7Q36571830-1D1E0F97-1299-47E9-925B-FC450B2BE990Q36675240-A2416B2F-B22F-4211-8A4B-7FCFE5AEFD57Q36676194-E7DA9AE9-6375-4864-A62A-9ED61D905020Q36785811-71C6A475-9F20-4C3B-A5E4-E5B4BECDADA8Q37642379-41F648F0-6E62-4A46-8B8A-C44ADF0424A6Q37646705-3BCF8735-723C-4FA8-BE17-AA94E9B7E0CFQ38010519-FB2665BE-F0AA-482D-8403-4A4B85AFEBAAQ38032506-8F75B1C1-32C0-4A5C-874B-84FEC343476BQ38082736-C66EE7B7-69B1-4AB6-B0A2-9915289C31ACQ38121929-5F12D120-D200-420E-9F58-B424A8B53119Q38121930-70963BAC-B100-4A98-AC43-6D0566104EBCQ38258065-3B6B4970-AA8A-42B4-80B1-63DEA8EFFB48Q38673550-B8F3C098-009C-494C-8361-358ACB372D2FQ40608479-6D8C9A03-0181-4115-A9DB-1BB31BBBCA71Q40997447-D3AABEAE-69EF-4A1D-B528-8806AFDB558AQ41082058-EC88F83B-A565-4C68-A83A-2A1CA7FDB64CQ41387428-CE765FAC-65AB-4772-ADC6-99D67246BA10Q41712271-196BFC77-511F-46E2-9A05-0E3537294F80Q42104270-35A6669E-E52F-4534-B233-BA43D2CD8894Q43108539-0B7051E2-55E4-4E0A-A1CE-E55EB72D84A1Q44425796-C12C9412-010E-4F7B-BFEF-77CE50BDCFF4Q46526975-68395D3F-1FC2-4148-B2CA-BA2BFC204442
P2860
Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Mupirocin resistance after lon ...... g chronic peritoneal dialysis.
@en
type
label
Mupirocin resistance after lon ...... g chronic peritoneal dialysis.
@en
prefLabel
Mupirocin resistance after lon ...... g chronic peritoneal dialysis.
@en
P2093
P356
P1476
Mupirocin resistance after lon ...... g chronic peritoneal dialysis.
@en
P2093
Ana Rodríguez-Carmona
Francisco Valdés
Miguel Pérez-Fontán
Miguel Rosales
Teresa García Falcón
P304
P356
10.1053/AJKD.2002.30553
P577
2002-02-01T00:00:00Z